Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users

Contraception

Volumn 81, Issue 5, 2010, Pages 408-413

  Dore, David D ^a,b   Norman, Heather ^a   Loughlin, Jeanne ^a   Seeger, John D ^a,c  

^a i3 Drug Safety   (United States)

^b BROWN UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Case control study; Pharmacoepidemiology; Transdermal contraceptive; Venous thromboembolism

Indexed keywords

ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORGESTIMATE;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HEALTH INSURANCE; HORMONAL CONTRACEPTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; OUTCOME ASSESSMENT; RISK ASSESSMENT; STROKE;

ADMINISTRATION, CUTANEOUS; ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, COMBINED; ETHINYL ESTRADIOL; FEMALE; HUMANS; MYOCARDIAL INFARCTION; NORGESTREL; RISK ASSESSMENT; STROKE; VENOUS THROMBOEMBOLISM;

EID: 77950859329     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.12.009     Document Type: Article

References (12)

1. Cole J.A., Norman H., Doherty M., and Walker A.M. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 109 (2007) 339-346
2. Cole J.A., Norman H., Doherty M., and Walker A.M. Corrections. Obstet Gynecol 111 (2008) 1449
3. Dore D.D., Norman H., and Seeger J.D. Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 114 (2009) 175
4. Jick S.S., Kaye J.A., Russmann S., and Jick H. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception 73 (2006) 223-228
5. Jick S., Kaye J.A., Li L., and Jick H. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception 76 (2007) 4-7
6. Jick S.S., and Jick H. The contraceptive patch in relation to ischemic stroke and acute myocardial infarction. Pharmacotherapy 27 (2007) 218-220
7. van den Heuvel M.W., van Bragt A.J., Alnabawy A.K., and Kaptein M.C. Comparison of ethinyl estradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception 72 (2005) 168-174
8. National Death Index. National Center for Health Statistics. Available from:. http://www.cdc.gov/nchs/ndi.htm [Accessed 22 May 2009]
9. Crystal S., Akincigil A., Bilder S., and Walkup J.T. Studying prescription drug use and outcomes with Medicaid claims data: strengths, limitations, and strategies. Med Care 45 (2007) S58-65
10. Walker A.M. Pattern recognition in health insurance claims databases. Pharmacoepidemiol Drug Saf 10 (2001) 393-397
11. Jurek A.M., Greenland S., and Maldonado G. How far from non-differential does exposure or disease misclassification have to be to bias measures of association away from the null?. Int J Epidemiol 37 (2008) 382-385
12. Phelps J.Y., and Kelver M.E. Confronting the legal risks of prescribing the contraceptive patch with ongoing litigation. Obstet Gynecol 113 (2009) 712-716